Acadia Healthcare Company, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K, dated January 4, 2016, discloses a material definitive agreement entered into on December 31, 2015. Acadia Healthcare Company, Inc. ("Acadia") agreed to acquire Priory Group No. 1 Limited ("Priory"), a leading provider of behavioral healthcare services in the United Kingdom operating over 300 facilities with approximately 7,200 beds. The transaction is scheduled to close on February 16, 2016.
Key Financial Metrics and Transaction Structure
The filing details the consideration for the acquisition of Priory, which includes both equity and cash components:
- Equity Consideration: Issuance of approximately 5.363 million shares of Acadia common stock to Institutional Sellers.
- Cash Consideration: Approximately £1.275 billion (approx. $1.887 billion).
- Debt Repayment: Approximately £925 million (approx. $1.369 billion) of the cash consideration is designated to repay outstanding debt facilities of the Target Companies.
- Financing Plan: Acadia intends to raise net proceeds of at least £400 million via a public offering of common stock to fund a portion of the cash consideration.
- Debt Commitment: Bank of America, N.A. and Jefferies Finance LLC have committed to provide up to $955 million in senior secured term loan B facilities and $390 million in senior unsecured bridge loans.
Material Changes and Agreements
The primary material change is the entry into the Sale and Purchase Deed for the Priory acquisition. Concurrently, Acadia entered into a Third Amended and Restated Registration Rights Agreement, granting Institutional Sellers "demand" and "piggyback" registration rights for Acadia securities. The filing notes that Acadia is restricted from taking certain actions, such as equity issuances, dividend payments, asset sales, or incurring new debt, until the earlier of the Closing or termination of the Agreement.
Outlook, Risks, and Contingencies
The transaction is subject to several contingencies and risks:
- Financing Contingency: While the Closing is not explicitly conditioned on financing, the Debt Financing is subject to customary conditions. If the public offering fails to raise agreed-upon cash levels, Acadia may issue additional shares to Institutional Sellers to meet a valuation target of approximately $337.5 million, or the Sellers may terminate the Agreement.
- Regulatory Approval: Either party may terminate the Agreement if the UK Competition and Markets Authority imposes orders prohibiting the Closing.
- Forward-Looking Statements: The filing includes standard disclaimers that actual results may differ materially from expectations due to risks and uncertainties outside Acadia's control.
Investor Verification Checklist
- Verify the final closing date and whether the February 16, 2016 target is met.
- Confirm the success of the public offering intended to raise at least £400 million.
- Monitor the status of the UK Competition and Markets Authority review.
- Review the final terms of the debt financing, specifically the conversion of the $390 million bridge loan into long-term debt.
- Assess the impact of the 5.363 million share issuance (plus potential additional shares) on existing shareholder dilution.